EP300 and otopalatodigital syndrome type 1: It would therefore be of great interest to follow glucose regulation in a larger cohort of Rubistein-Taybi syndrome patients with specific p300 mutations to further ascertain association between p300 loss and diabetes-like phenotypes in humans.